Mesoblast MESO
NASDAQ MESO
$17.32 +0.18 (+1.05%)
At close: Sep 4, 2026 · 4:00 PM EDT

Mesoblast (MESO) Accounts Payables (2015 - 2026)

Mesoblast (MESO) posted Accounts Payables of $33.6 million for Q4 2025, up 75.96% sequentially from $19.1 million in Q2 2025, and up 183.1% YoY from $11.9 million in Q4 2024.

Analysis

Mesoblast (MESO) Accounts Payables (2015 - 2026) Analysis & Trends

Mesoblast has reported Accounts Payables for 11 years, with the latest figure at $33.6 million in Q4 2025.

  • Quarterly Accounts Payables rose 183.1% year-over-year to $33.6 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $33.6 million (up 183.1% YoY) and the FY2025 annual result came in at $19.1 million, up 169.9% from the prior year.
  • Accounts Payables grew to $33.6 million in Q4 2025 per MESO's latest filing, from $19.1 million in the prior quarter.
  • Over five years, Accounts Payables peaked at $33.6 million in Q4 2025 and troughed at $7.1 million in Q2 2024.
  • A 5-year average of $19.1 million and a median of $19.6 million in 2021 frame the typical range for Accounts Payables.
  • The sharpest annual moves came in 2024 and 2025: Accounts Payables plunged 64.9% in 2024, then soared 183.1% in 2025.
  • Over 5 years, Accounts Payables stood at $20.9 million in 2021, then increased by 9.91% to $23.0 million in 2022, then sank by 53.2% to $10.8 million in 2023, then grew by 10.22% to $11.9 million in 2024, then jumped by 183.1% to $33.6 million in 2025.
  • According to Business Quant data, Accounts Payables over the past three periods registered $33.6 million, $19.1 million, and $11.9 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 429.50 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 1.16 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn 1.52 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 167.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 88.42 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 470.30 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 108.02 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 35.57 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 428.93 Mn
10 Mesoblast 2.24 Bn 2.14 Bn - 46.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 46.81 Mn
Dec 31, 2025 33.58 Mn
Jun 30, 2025 19.08 Mn
Dec 31, 2024 11.86 Mn
Jun 30, 2024 7.07 Mn
Dec 31, 2023 10.76 Mn
Jun 30, 2023 20.15 Mn
Mar 31, 2023 20.97 Mn
Dec 31, 2022 22.99 Mn
Sep 30, 2022 17.66 Mn
Jun 30, 2022 23.08 Mn
Mar 31, 2022 18.98 Mn
Dec 31, 2021 20.92 Mn
Sep 30, 2021 16.26 Mn
Jun 30, 2021 19.60 Mn
Mar 31, 2021 24.28 Mn
Dec 31, 2020 28.61 Mn
Sep 30, 2020 27.60 Mn
Jun 30, 2020 24.97 Mn
Mar 31, 2020 19.48 Mn